Clear Course for Profitable Growth 1Q 2025 Earnings Call May 6, 2025 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, relating to our business and financial outlook, which are based on our current beliefs, assumptions, intentions, plans, expectations, estimates, forecasts and projections. In some cases, you can identify forward-looki ...

Q1 2025 Financial Results May 6, 2025 (Nasdaq: SEAT) Agenda Business Highlights & Updates Stan Chia, Chief Executive Officer 2 Financial Results & Outlook Lawrence Fey, Chief Financial Officer Important Disclaimers Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "can," "continue," "could," "design," "estimate," "expect," "f ...

Non-GAAP Financial Measures In this presentation, we include certain non-GAAP financial measures, including Net Debt, Adjusted Net Earnings and Adjusted EPS, net sales on an "organic" and a "constant dollar" basis, Free Cash Flow, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Tax Rate. Management uses non-GAAP financial measures to assess operating and financial performance, set budgets, provide guidance and compare with peers' performance. We believe such non-GAAP financial measures are useful to in ...

RESULTS NASDAQ GLOBAL MARKET: CCLD, CCLDO A healthcare technology company with 25 years of experience, delivering AI-driven, end-to-end solutions that power real-world clinical and financial transformation. © CareCloud, Inc. 2025 This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by ...

Financial Performance - Net sales reached $1.046 billion, an 8% increase year-over-year[10] - Net income was $49 million, representing 4.7% of net sales, a 35% increase year-over-year[10] - Adjusted EBITDA was $111 million, or 10.6% of net sales, up 23% year-over-year[10] - First quarter operating profit margin increased to 7.8%, up 180 bps year-over-year[10] Capital Allocation and Liquidity - The company has a strong liquidity position with $231 million in cash and cash equivalents and $595 million available on the revolving credit facility as of March 31, 2025[11] - $57.6 million was returned to shareholders through dividends of $1.15 per share, totaling $29.4 million, and $28.3 million in share repurchases[11] Segment Performance - RV OEM sales increased by 15% year-over-year in Q1 2025[17] - Adjacent Industries OEM sales decreased by 2% year-over-year in Q1 2025[27] - Aftermarket segment sales increased by 6% year-over-year in Q1 2025[32] Strategic Initiatives - The company acquired Trans/Air in March and Freedman Seating in April, representing approximately $200 million in annual revenues in the bus market[11] - The company is on track to deliver an additional 85 bps margin improvement in 2025 through optimizing infrastructure[10, 71]

First Quarter 2025 Earnings Non-GAAP Financial Measures This presentation includes non-GAAP financial measures not presented in accordance with U.S. GAAP. A reconciliation of the most comparable GAAP measure to its non-GAAP measure is included in the appendix. Adjusted EBITDA May 6, 2025 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as ame ...

Financial Performance - Q1 2025 - Celsius Holdings' total revenue decreased by 7% year-over-year to $329.3 million[28] - North America revenue decreased by 10% year-over-year to $306.5 million[28] - International revenue increased by 41% year-over-year to $22.8 million[27, 28] - Net income decreased by 43% to $44.4 million[28] - Adjusted EBITDA decreased by 21% to $69.7 million, with an Adjusted EBITDA Margin of 21.2%[28, 49] Market Position and Growth - Celsius Holdings is the 1 growth brand in RTD (Ready-to-Drink) energy[15] - Celsius Holdings' portfolio is the 3 energy drink portfolio in the U.S with a 15.5% market share in 2024[19] - The acquisition of Alani Nu closed on April 1, with the brand surpassing $1 billion in retail sales in the last 52 weeks[23] - Celsius Holdings portfolio drove approximately 20% of category growth in Q1[23] Key Metrics - Full Year 2024 - Revenue reached $1.36 billion[19] - Gross Margin was 50.2%[19] - Net Income was $145 million[19] - Adjusted EBITDA was $256 million, with an Adjusted EBITDA Margin of 18.9%[19] Retail Sales - Total retail sales in the U.S reached $3.5 billion in 2024[16] - Brand CELSIUS® holds 98.7% ACV and is sold in over 241,000 U.S retail outlets[19]

May 6, 2025 AEP First Quarter 2025 Earnings Presentation AEP CONFIDENTIAL Cautionary Note Regarding Forward- Looking Statements This presentation contains forward-looking statements. Words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue" and similar expressions, and include statements reflecting future results or guidance and statements of outlook are intended to identify forward-looking statements but are not the exclusive means of ident ...

1Q 2025 earnings May 6, 2025 +5% Adjusted net revenue growth1 +70 bps Forward-looking statements This presentation may contain certain forward-looking statements within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on current expectations, estimates and projections about the industry and markets in which we operate, and beliefs of and assumptions made by our management, involve risks, uncertainties and a ...

Company Overview and Platform - SOPHiA GENETICS's AI platform SOPHiA DDM is used by over 800 healthcare institutions globally [7] - The platform analyzes over 350,000 patients per year and has analyzed over 2 million profiles since inception [8, 21] - The company has invested over $450 million since inception in its AI platform [21] Market Trends and Data Analysis - Healthcare data accounts for 30% of all data generated globally [17] - In 2024, SOPHiA DDM performed over 350,000 genomic analyses, with over 93,000 in Q1 2025 [33] - Total data processed on SOPHiA DDM has seen compounded growth of over 50% since 2021 [46] Financial Performance and Outlook - SOPHiA GENETICS' revenue for 2024 was $65.2 million [68] - The company projects revenue between $72 million and $76 million for 2025, representing approximately 10% to 17% year-over-year growth [71] - Adjusted gross margin was 72.8% in 2024 and is expected to expand slightly in 2025 [71] - The company had a cash balance of $68.5 million as of Q1 2025 [76]